The US Food and Drug Administration granted approval to Israel-based Teva Pharmaceuticals to market its generic epinephrine auto-injector for emergency treatment of allergic reactions.
US approves first generic competitor to Mylan's $600 EpiPen
The US Food and Drug Administration granted approval to Israel-based Teva Pharmaceuticals to market its generic epinephrine auto-injector for emergency treatment of allergic reactions.